FIELD: medicine.
SUBSTANCE: invention relates to drug dosage form for administration once a day, which contains 6'-fluoro-(N-methyl-or N,N-dimethyl)-4-phenyl-4',9'-dihydro-3'N-spiro[cyclohexane-1,1'-pyrano [3,4,b]indole]-4-amine or its physiologically acceptable salt and anionic surfactant with HLB index at least of 10.
EFFECT: drug dosage form under the invention releases at least 80 wt% of above pharmaceutical active substance through 30 minutes and provides adequate fast and reliable pain relief for long period of time without additional measures.
13 cl, 1 dwg, 11 tbl, 3 ex
| Title |
Year |
Author |
Number |
| DRUG DOSAGE FORM CONTAINING 6'-FLUORO-(N-METHYL-OR N, N-DIMETHYL-)-4-PHENYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1, 1'-PYRANO[3, 4, b]INDOLE]-4-AMINE |
2011 |
- Gryuning Nadya
- Shiller Mark
|
RU2589830C2 |
| DOSED DRUG FORM CONTAINING 6-FLUORO-(N-METHYL- OR N,N-DIMETHYL-)-4-PHENYL-4', 9'-DIHYDRO-3'N-SPIRO[CYCLOHEXANE-1,1'-PYRANO[3,4,INDOLE]-4-AMINE FOR NOCICEPTIVE PAIN TREATMENT |
2011 |
- Gryuning Nadya
- Shiller Mark
- Fridrikh Ingo
- Kerbi Kris
- Khemani Ashish
- Botmer Jokhn
- Sholts Andreas
|
RU2631481C2 |
| MEDICINAL DOSAGE FORM, WHICH CONTAINS 6'-FLUOR-(N-METHYL-OR N,N-DIMETHYL)-4-PHENYL-4,9'-DIHYDRO-3'N-SPIRO[CYCLOHEXANE-1,1'-PYRANO[3,4, B]INDOLE]-4-AMINE FOR NEUROPATHIC PAIN TREATMENT |
2011 |
- Gryuning Nadya
- Shiller Mark
- Fridrikh Ingo
- Kerbi Kris
- Khemani Ashish
- Botmer Jokhn
- Sholts Andreas
|
RU2638818C2 |
| MEDICINAL DOSAGE FORM, WHICH CONTAINS 6'-FLUOR-(N-METHYL-OR N,N-DIMETHYL)-4-PHENYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1,1'-PYRANO[3,4,b]INDOLE]-4-AMINE |
2011 |
- Shiller Mark
- Grjuning Nadja
- Fridrikh Ingo
- Kerbi Kris
|
RU2582390C2 |
| TOSYLATE SALT OF TRANS-N-ISOBUTYL-3-FLUORO-3-[3-FLUORO-4-(PYRROLIDIN-1-YLMETHYL)PHENYL]CYCLOBUTANE CARBOXAMIDE |
2008 |
- Vager Trevis T.
- Batler Todd Uill'Jam
|
RU2451016C2 |
| PHARMACEUTICAL COMBINATIONS CONTAINING 3-(3-DIMETHYLAMIN-1-ETHYL-2-METHYLPROPYL)-PHENOL AND PARACETAMOL |
2007 |
- Bloms-Funke Petra
- Shine Klaus
|
RU2442576C2 |
| CRYSTALLINE FORMS OF 3-(2,6-DICHLORO-3,5-DIMETHOXYPHENYL)-1-{ 6-[4-(4-ETHYLPIPERAZIN-1-YL)-PHENYLAMINO]-PYRIMIDIN-4-YL} -1-METHYLUREA AND ITS FRACTIONS |
2010 |
- Jerg Bergkhauzen
- Prasad Kotesvara Kapa
- Dzhozef Makkenna
- Dzhoehl Slejd
- Rejann Vu
- Chzhehnmin Du
- Frank Shtovasser
|
RU2572848C2 |
| PHARMACEUTICAL DRUG FORM OF TYROSINE KINASE INHIBITOR FOR PERORAL INTRODUCTION |
2007 |
- Lipol'D Bernd
- Rozenberg Jorg
- Knoblokh Martin
- Nehen Kristian
|
RU2468788C2 |
| COMPOSITION COMPRISING N-{5-[4-(4-METHYLPIPERAZINOMETHYL)BENZOYLAMIDO]-2-METHYLPHENYL}-4-(3-PYRILYL)-2-PYRIDINEAMINE AND CHEMOTHERAPEURIC AGENT |
2002 |
- Bruns Kristian
- Bukhdunger Ehlizabet
- O`Rejlli Terens
- Silberman Sandra Lita
- Vartmann Markus
- Vekkbekker Gizbert
|
RU2318517C2 |
| [4-(5-AMINOMETHYL-2-FLOUROPHENYL)-PYPERIDIN-1-YL]-(4-BROMINE-3-PROPOXYTHIOPHENE-2-YL)-METHALON HYDROCHLORIDE AS INHIBITOR OF MAST CELLS TRYPTASE |
2005 |
- Gao Chzhunli
- Dehvis Larri
- Levell Dzhulian
- Chekaj Mark
- Sledeski Adam V.
- Addad Ehl'-Bdaui
|
RU2330034C1 |
